Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-18 to 2024-09-29
Current total value of award: $263016.1
Description: THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES